|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 98.60 TWD | -0.30% |
|
+4.56% | -67.57% |
| Market Cap | 6.59B 204M 176M 165M 151M 284M 19.41B 289M 1.93B 759M 9.73B 766M 749M 32.16B | P/E 2024 |
524x | P/E 2025 | -255x |
|---|---|---|---|---|---|
| Enterprise Value | 4.29B 133M 115M 107M 98.52M 185M 12.65B 188M 1.26B 495M 6.34B 499M 488M 20.97B | EV / Sales 2024 |
1,207x | EV / Sales 2025 | 6,544x |
| Free-Float |
56.63% | Yield 2024 |
0.18% | Yield 2025 | 0.03% |
| 1 day | -0.30% | ||
| 1 week | +4.56% | ||
| Current month | +4.56% | ||
| 1 month | -15.73% | ||
| 3 months | -28.03% | ||
| 6 months | -61.41% | ||
| Current year | -67.57% |
| 1 week | 96.2 |  | 99 |
| 1 month | 92 | | 118 |
| Current year | 92 | | 313 |
| 1 year | 92 | | 317 |
| 3 years | 92 | | 465 |
| 5 years | 42.8 | | 465 |
| 10 years | 42.8 | | 465 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yung Shun Wen
CEO | Chief Executive Officer | - | 2016-09-22 |
Vivian Kang
DFI | Director of Finance/CFO | - | 2019-10-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Lin
CHM | Chairman | - | 2016-09-22 |
Yung Shun Wen
BRD | Director/Board Member | - | 2016-09-22 |
Cheng Yu Fang
BRD | Director/Board Member | - | 2018-08-06 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.30% | +4.56% | -45.22% | -26.96% | 204M | |
| +0.16% | -1.24% | +59.35% | +21.19% | 317B | |
| -1.03% | +0.35% | +32.89% | -11.41% | 72.2B | |
| +20.24% | +24.93% | +63.94% | +141.90% | 11.7B | |
| +1.55% | +2.70% | -1.39% | -3.17% | 8.45B | |
| +2.28% | +8.10% | -14.26% | -14.00% | 4.75B | |
| +14.37% | +22.10% | +4.25% | +50.44% | 4.38B | |
| +3.60% | +9.66% | -28.04% | +8.36% | 4.26B | |
| +1.88% | +6.74% | +15.55% | +56.04% | 2.77B | |
| +4.26% | +0.31% | +1.17% | +0.23% | 2.26B | |
| Average | +4.69% | +7.60% | +8.82% | +22.26% | 42.82B | |
| Weighted average by Cap. | +0.77% | +0.31% | +50.93% | +18.38% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 5.82M 180K 156K 146K 133K 251K 17.14M 255K 1.71M 670K 8.59M 676K 662K 28.41M | 2.75M 85.25K 73.74K 68.86K 63.17K 119K 8.11M 121K 808K 317K 4.07M 320K 313K 13.44M |
| Net income | 18.17M 563K 487K 454K 417K 784K 53.55M 797K 5.33M 2.09M 26.84M 2.11M 2.07M 88.73M | -79.68M -2.47M -2.13M -1.99M -1.83M -3.44M -235M -3.49M -23.38M -9.18M -118M -9.27M -9.06M -389M |
| Net Debt | -2.43B -75.26M -65.1M -60.79M -55.77M -105M -7.16B -107M -713M -280M -3.59B -283M -276M -11.87B | -2.29B -71M -61.41M -57.35M -52.61M -98.95M -6.76B -101M -673M -264M -3.39B -267M -261M -11.2B |
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | NT$98.60 | -0.30% | 28,211 |
| 26-08-06 | NT$98.90 | +0.51% | 30,774 |
| 26-08-05 | NT$98.40 | +0.72% | 61,098 |
| 26-08-04 | NT$97.70 | +1.24% | 33,736 |
| 26-08-03 | NT$96.50 | +2.33% | 50,344 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 6785 Stock
Select your edition
All financial news and data tailored to specific country editions
